Dr. Reddy's Laboratories to Reportedly Sell Generic Version of Novo Nordisk's Ozempic From March

MT Newswires Live01-21

Dr. Reddy's Laboratories (RDY) intends to sell a generic version of Novo Nordisk's (NVO) Ozempic diabetes drug following the expiry of its patent in March, several media outlets reported Wednesday, citing company officials.

The company is planning to manufacture and sell 12 million pens consisting of generic semaglutide, the active ingredient in Ozempic, in the first year after launch, according to reports.

Dr. Reddy's will collaborate with other firms in India to launch the generic product, the reports said.

The company did not immediately respond to an MT Newswires request for comment.

Price: 13.16, Change: +0.22, Percent Change: +1.66

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2605248694?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-21 23:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605248694","market":"sh","top_or_hot":-1,"title":"Dr. Reddy's Laboratories to Reportedly Sell Generic Version of Novo Nordisk's Ozempic From March","media":"MT Newswires Live","content":"<html><body><p> Dr. Reddy's Laboratories (RDY) intends to sell a generic version of <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s (NVO) Ozempic diabetes drug following the expiry of its patent in March, several media outlets reported Wednesday, citing company officials.</p><p>The company is planning to manufacture and sell 12 million pens consisting of generic semaglutide, the active ingredient in Ozempic, in the first year after launch, according to reports.</p><p>Dr. Reddy's will collaborate with other firms in India to launch the generic product, the reports said.</p><p>The company did not immediately respond to an MT Newswires request for comment.</p><p>Price: 13.16, Change: +0.22, Percent Change: +1.66</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dr. Reddy's Laboratories to Reportedly Sell Generic Version of Novo Nordisk's Ozempic From March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDr. Reddy's Laboratories to Reportedly Sell Generic Version of Novo Nordisk's Ozempic From March\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-21 23:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Dr. Reddy's Laboratories (RDY) intends to sell a generic version of <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s (NVO) Ozempic diabetes drug following the expiry of its patent in March, several media outlets reported Wednesday, citing company officials.</p><p>The company is planning to manufacture and sell 12 million pens consisting of generic semaglutide, the active ingredient in Ozempic, in the first year after launch, according to reports.</p><p>Dr. Reddy's will collaborate with other firms in India to launch the generic product, the reports said.</p><p>The company did not immediately respond to an MT Newswires request for comment.</p><p>Price: 13.16, Change: +0.22, Percent Change: +1.66</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RDY","symbol_name":"如瑞迪博士","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2605248694","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605248694","pubTimestamp":1769009875,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Dr. Reddy's Laboratories  intends to sell a generic version of Novo Nordisk's  Ozempic diabetes drug following the expiry of its patent in March, several media outlets reported Wednesday, citing company officials.The company is planning to manufacture and sell 12 million pens consisting of generic semaglutide, the active ingredient in Ozempic, in the first year after launch, according to reports.Dr. Reddy's will collaborate with other firms in India to launch the generic product, the reports said.The company did not immediately respond to an MT Newswires request for comment.Price: 13.16, Change: +0.22, Percent Change: +1.66","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RDY":"如瑞迪博士","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","BK4523":"印度概念","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4557":"大麻股","LU0348744763.USD":"ALLIANZ ASIA PACIFIC INCOME \"A\" (USD) INC","BK4532":"文艺复兴科技持仓","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4599":"减肥药","BK4596":"哈里斯概念","BK4007":"制药","BK7104":"黄金","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK7016":"应用软件","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"据报道，Reddy博士的实验室将从3月份开始销售诺和诺德Ozempic的仿制药","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RDY":1.94},"content_text":"Dr. Reddy's Laboratories (RDY) intends to sell a generic version of Novo Nordisk's (NVO) Ozempic diabetes drug following the expiry of its patent in March, several media outlets reported Wednesday, citing company officials.The company is planning to manufacture and sell 12 million pens consisting of generic semaglutide, the active ingredient in Ozempic, in the first year after launch, according to reports.Dr. Reddy's will collaborate with other firms in India to launch the generic product, the reports said.The company did not immediately respond to an MT Newswires request for comment.Price: 13.16, Change: +0.22, Percent Change: +1.66","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605248694","isCrawlerRequest":true}